Close

Aeterna Zentaris (AEZS), Rafa Laboratories Sign License Agreement for Zoptrex in Israel

August 1, 2016 8:34 AM EDT Send to a Friend
Aeterna Zentaris Inc. (NASDAQ: AEZS) and Rafa Laboratories, Ltd. (“Rafa”) today announced the signing of an exclusive license agreement for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login